We are live on
!
Find out more
JLBC
J.L. Bainbridge & Co Portfolio holdings
AUM
$1.27B
1-Year Est. Return
26.55%
This Fund
S&P 500
This Quarter
Est. Return
+10.02%
1 Year Est. Return
+26.55%
3 Year Est. Return
+93.81%
5 Year Est. Return
+120.16%
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$95.9M
(+8.7%)
Cap. Flow
-$108K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
60.79%
Holding
112
New
7
Increased
29
Reduced
51
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$45.6M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$1.62M |
| 3 |
Cigna
CI
|
+$1.42M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$712K |
| 5 |
MAXJ
iShares Large Cap Max Buffer Jun ETF
MAXJ
|
+$398K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$16.1M |
| 2 |
Delta Air Lines
DAL
|
+$14.8M |
| 3 |
Becton Dickinson
BDX
|
+$6.61M |
| 4 |
Apple
AAPL
|
+$3.79M |
| 5 |
Salesforce
CRM
|
+$1.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.11% |
| 2 | Communication Services | 16.08% |
| 3 | Financials | 14.12% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 7.67% |
Similar funds
EIA
TC
CAM
FBCM
SA
NCM
TWP
TBC
J.L. Bainbridge & Co's Q3 2025 Portfolio in Review
As of Q3 2025, J.L. Bainbridge & Co held 112 positions worth $1.2B, up 8.7% from $1.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
J.L. Bainbridge & Co's Q3 2025 filing shows 7 new, 29 increased, 51 reduced and 5 closed positions. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 484 shares worth $288K. The largest sale was Biogen, an estimated $16.1M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Communication Services and Financials.
- J.L. Bainbridge & Co's largest Q3 2025 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 484 shares worth $288K.
- J.L. Bainbridge & Co added most to Eli Lilly in Q3 2025, an estimated $45.6M increase.
- J.L. Bainbridge & Co's biggest Q3 2025 reduction was Biogen, cutting an estimated $16.1M.
- J.L. Bainbridge & Co fully exited Becton Dickinson in Q3 2025, selling an estimated $6.61M.
- J.L. Bainbridge & Co's ten largest holdings make up 61% of its $1.2B portfolio in Q3 2025.
- J.L. Bainbridge & Co opened 7 new positions and closed 5 in Q3 2025.
- J.L. Bainbridge & Co's portfolio value rose 8.7% quarter-over-quarter to $1.2B.
Based on J.L. Bainbridge & Co's 13F filing for Q3 2025, filed 17 Oct 2025.